Clinical analysis of 23 cases of disseminated bacillus Calmette-Guerin disease

卢水华,李涛,席秀红,郭建,黄富礼,张文宏,刘旭晖,范小勇

DOI: https://doi.org/10.3760/cma.j.issn.1000-6680.2013.07.009

2013-01-01

Abstract:Objective To explore the clinical characteristics,diagnosis,treatment and prognosis of disseminated bacillus Calmette-Guerin (BCG) disease.Methods A retrospective study was performed on 23 children diagnosed with disseminated BCG disease at Shanghai Public Health Clinical Center from March 2006 to June 2011.The diagnosis,clinical features,underlying immunodeficiency,treatment and prognosis were evaluated.Results Among the 23 children,13 were male and 10 were female.The age of patients was from 2 months to 5 years old when diagnosed (median age,14.5 months).Clinical manifestations included fever in 23 cases,night sweats in 15.Thoracic and abdominal computed tomography of the 23 cases showed infiltrations or miliary lesion of the lungs with hilar,mediastinal and abdominal lymphadenopathy.Tuberculin skin tests (TST) were positive in 60.9％ (14/23),and interferon gamma release assay (IGRA) was positive in 23.1％ (3/13).Among the 23 cases,14 cases were diagnosed with primary combined immunodeficiency disease.Co-infections were observed in 14 out of 23 patients.All patients were given 2-4 antituberculous agents,including 12 severe cases with additional linezolid,and 16 cases with thymosin.During follow-up,there were 7 deaths (30.4％).Conclusions Clinical diagnostic criteria of disseminated BCG disease needs to be advised.Disseminated BCG disease tends to occur in children with immunodeficiency.The prognosis is poor and treatment options is limited at present.